The prevalence of various mental disorders and their impact on mortality among cancer survivors were assessed. The results revealed that mental disorders significantly increased the risk of all-cause…
Sponsored by Astellas Pharma US, Inc. and Pfizer Inc. Neal Shore, MD, FACS GenesisCare US Myrtle Beach, South Carolina Stephen Freedland, MD Warschaw, Robertson, Law…
Registration details for AACR IO: Discovery and Innovation in Cancer Immunology: Revolutionizing Treatment through Immunotherapy
Panelists discussed recent U.S. Food and Drug Administration approvals, plus the importance of monitoring ovarian toxicity in breast cancer clinical trials.
Lucio Miele, MD, PhD of LSU has been appointed as director of the LSU-LCMC Health Cancer Center.
Nature Cancer – Sears and colleagues found that ongoing replication stress pathways and T cell clonal responses differentiate liver and lung recurrence and are associated…
Clinical and Translational Oncology – This review aims to summarize recent studies and findings within adoptive cell therapies, including tumor-infiltrating lymphocytes, genetically engineered T…
Recent studies have suggested some surprising things (not beaming from the center of our solar system) that might increase your risk for skin cancer. We…
SAN ANTONIO — The addition of camrelizumab to platinum-containing intensive neoadjuvant chemotherapy improved pathologic complete response for certain patients with triple-negative breast cancer. Camrelizumab (SHR-1210,…
Click to share this newsletter with your friends! Welcome to the January 2025 edition of the FDA Oncology Center of Excellence (OCE) quarterly newsletter from…
Key PointsForimtamig exhibits superior potency compared with other GPRC5D- and BCMA-targeting TCBs.Forimtamig combination with TCBs and CELMoDs prevents tu
